| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/17/2011 | WO2011032100A1 Inhibitors of kshv vil6 and human il6 |
| 03/17/2011 | WO2011032099A1 Methods of treating diastolic dysfunction and related conditions |
| 03/17/2011 | WO2011032050A2 Gyrase inhibitors |
| 03/17/2011 | WO2011032000A2 Method for protection of antimicrobial and anticancer drugs from inactivation by nitric oxide |
| 03/17/2011 | WO2011031974A1 Acridine analogs in the treatment of gliomas |
| 03/17/2011 | WO2011031965A1 Modulators of toll-like receptors |
| 03/17/2011 | WO2011031935A1 Selective antibacterials for clostridium difficile infections |
| 03/17/2011 | WO2011031934A1 Hepatitis c virus inhibitors |
| 03/17/2011 | WO2011031926A1 Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyridyl)-1-[2-[4-pyridyl)ethyl]propanamide and uses thereof |
| 03/17/2011 | WO2011031921A1 Treatment of cancer using the sodium salt of a benzoic acid derivative |
| 03/17/2011 | WO2011031919A2 Non-radioactive phospholipid compounds, compositions, and methods of use |
| 03/17/2011 | WO2011031904A1 Hepatitis c virus inhibitors |
| 03/17/2011 | WO2011031890A2 Cancer stem cell-targeted and drug resistant cancer therapy |
| 03/17/2011 | WO2011031884A2 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |
| 03/17/2011 | WO2011031865A1 Cyclodextrin-based polymers for therapeutic delivery |
| 03/17/2011 | WO2011031852A1 Sodium channel blocker delivery system with scleral lens |
| 03/17/2011 | WO2011031849A2 Anionic lipids and lipid nanostructures and methods of producing and using same |
| 03/17/2011 | WO2011031842A1 N-4 ( - ( ( 3- ( 2 -amino-4 pyrimidinyl) -2 -pyridinyl) oxy) phenyl) -4- (4-methyl-2-thienyl) -1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer |
| 03/17/2011 | WO2011031818A2 Histamine h3 inverse agonists and antagonists and methods of use thereof |
| 03/17/2011 | WO2011031816A2 Histamine h3 inverse agonists and antagonists and methods of use thereof |
| 03/17/2011 | WO2011031745A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031744A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031743A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031740A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031669A1 Inhibitors of flaviviridae viruses |
| 03/17/2011 | WO2011031621A2 High strength seamless alginate capsules |
| 03/17/2011 | WO2011031602A1 Nutritional compositions for modulating inflammation including exogenous vitamin k2 |
| 03/17/2011 | WO2011031601A2 Nutritional compositions including exogenous vitamin k2 |
| 03/17/2011 | WO2011031600A1 Use of il-33 antagonists to treat fibrotic disease |
| 03/17/2011 | WO2011031574A1 HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 03/17/2011 | WO2011031561A2 Nucleic acid molecules and uses thereof |
| 03/17/2011 | WO2011031503A2 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10) |
| 03/17/2011 | WO2011031482A2 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap |
| 03/17/2011 | WO2011031474A2 Use of metformin in cancer treatment and prevention |
| 03/17/2011 | WO2011031441A1 Therapy with a chimeric molecule and a pro-apoptotic agent |
| 03/17/2011 | WO2011031350A1 Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof |
| 03/17/2011 | WO2011031327A2 Nicotine haptens, immunoconjugates and their uses |
| 03/17/2011 | WO2011031308A1 Novel combinations |
| 03/17/2011 | WO2011031304A2 Compositions and methods for enhancing cognitive and related functions in animals |
| 03/17/2011 | WO2011031289A1 Novel medical uses for no and no donor compounds |
| 03/17/2011 | WO2011031237A1 Phytochemical compositions including sesamin for anti¬ inflammatory, anti-cytokine storm, and other uses |
| 03/17/2011 | WO2011031236A1 Phytochemical compositions including xanthones for anti-inflammatory, anti-cytokine storm, and other uses |
| 03/17/2011 | WO2011031180A1 Method for stimulating super ovulation in donor cows |
| 03/17/2011 | WO2011031176A1 Oral suspension formulations of esclicarbazepine acetate |
| 03/17/2011 | WO2011031111A2 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 03/17/2011 | WO2011031100A2 Aripiprazole-bentonite-aea hybrid, pharmaceutical composition containing the same and method for preparing the same |
| 03/17/2011 | WO2011031099A9 Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same |
| 03/17/2011 | WO2011031099A2 Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same |
| 03/17/2011 | WO2011031018A2 Water-soluble drug delivery system allowing slow release |
| 03/17/2011 | WO2011030992A1 Curable bicyclic compound derived from biomass, solvent-free curable composition, and method for preparing same |
| 03/17/2011 | WO2011030981A1 Method for preparing [18f]fallypride with low base concentration |
| 03/17/2011 | WO2011030929A1 Compound for inhibiting type 3 17β-hydroxysteroid dehydrogenase |
| 03/17/2011 | WO2011030927A1 Compound for inhibiting type-3 17β-hydroxysteroid dehydrogenase |
| 03/17/2011 | WO2011030903A1 Composition for alleviating ultraviolet radiation-induced damage |
| 03/17/2011 | WO2011030873A1 Benzyl compounds |
| 03/17/2011 | WO2011030872A1 Sulfonamide compounds |
| 03/17/2011 | WO2011030871A1 N-substituted heteroaryl compounds |
| 03/17/2011 | WO2011030868A1 Substituted carbonyl compounds |
| 03/17/2011 | WO2011030865A1 Substituted zenzyl compounds |
| 03/17/2011 | WO2011030864A1 Aniline compounds |
| 03/17/2011 | WO2011030859A1 Skin-whitening composition |
| 03/17/2011 | WO2011030847A1 Inducer composition for hematopoietic stem cells |
| 03/17/2011 | WO2011030841A1 Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4) |
| 03/17/2011 | WO2011030798A1 8-oxodihydropurine derivative |
| 03/17/2011 | WO2011030727A1 External preparation containing pantethine phosphate ester |
| 03/17/2011 | WO2011030575A1 Therapeutic agent for chronic pain |
| 03/17/2011 | WO2011030351A2 Taste - masked pharmaceutical compositions |
| 03/17/2011 | WO2011030349A1 L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands |
| 03/17/2011 | WO2011030329A1 Method of treating tumors |
| 03/17/2011 | WO2011030312A1 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
| 03/17/2011 | WO2011030224A2 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities |
| 03/17/2011 | WO2011030205A1 N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation |
| 03/17/2011 | WO2011030166A1 The use of lipid emulsions for binding hepatitus c virus |
| 03/17/2011 | WO2011030163A1 Use of guaifenesin for inhibiting mucin secretion |
| 03/17/2011 | WO2011030160A1 Detection of mycobacteria |
| 03/17/2011 | WO2011030139A1 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators |
| 03/17/2011 | WO2011030116A1 Use of steroid compounds for inflammatory and autoimmune disorders |
| 03/17/2011 | WO2011030106A1 Cancer cell apoptosis |
| 03/17/2011 | WO2011030104A1 Phenylacetate and/or phenylbutyrate (not ornithine) for reducing portal blood pressure |
| 03/17/2011 | WO2011030103A1 Screening method and therapy with agonists of ddah i |
| 03/17/2011 | WO2011029996A1 Use of vap-1 inhibitors for treating fibrotic conditions |
| 03/17/2011 | WO2011029956A1 Flavones and flavanones derivates as dna methyltransferases inhibitors |
| 03/17/2011 | WO2011029948A2 Transdermal therapeutic system for administering fentanyl or an analogue thereof |
| 03/17/2011 | WO2011029920A1 Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| 03/17/2011 | WO2011029915A1 Ether derivatives of bicyclic heteroaryls |
| 03/17/2011 | WO2011029909A1 Solid dispersion comprising an anti-hiv agent |
| 03/17/2011 | WO2011029903A1 Method for the preparation of micro-rna and its therapeutic application |
| 03/17/2011 | WO2011029868A1 Pharmaceutical formulation containing ribavirin |
| 03/17/2011 | WO2011029855A1 Pyrrolo-pyridine derivatives as activators of ampk |
| 03/17/2011 | WO2011029842A1 Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer |
| 03/17/2011 | WO2011029832A1 Novel thiazol and oxazol hepcidine antagonists |
| 03/17/2011 | WO2011029827A1 5- (3, 4-dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2, 2-trifluoro-ethoxy) -nico tinamide and salts thereof as hdl cholesterol raising agents |
| 03/17/2011 | WO2011029808A1 Hsl inhibitors useful in the treatment of diabetes |
| 03/17/2011 | WO2011029807A1 Ortho substituted pyrimidine compounds as jak inhibitors |
| 03/17/2011 | WO2011029804A1 Inhibitors of jak |
| 03/17/2011 | WO2011029803A1 2 -aminodihydro [1, 3] thiazines as bace 2 inhibitors for the treatment of diabetes |
| 03/17/2011 | WO2011029802A1 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| 03/17/2011 | WO2011029782A1 Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
| 03/17/2011 | WO2011029775A1 [1,2,4]TRIAZOLO [1,5-c]PYRIMIDINE DERIVATIVES AS Hsup90 MODULATORS |
| 03/17/2011 | WO2011029639A2 Compounds and methods for treating neoplasia |